June 6-9, 2016 – San Francisco, CA Longevity Biotech will participate as part of the Innovation zone Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s Disease
